ORIC ORIC PHARMACEUTICALS INC

Ownership history in VR Adviser, LLC  ·  11 quarters on record

This page tracks every 13F SEC filing in which VR Adviser, LLC reported a position in ORIC PHARMACEUTICALS INC (ORIC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
5.02% (2025 Q2)
Avg. % of fund
2.59%
First filed
2023 Q2
Last filed
2025 Q4
Quarters held
11
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 5,676,230 -920,655 -14.0% 2.29% $46.4M $8.18
2025 Q3 UNCHANGED 6,596,885 0% 4.46% $79.2M $12.00
2025 Q2 ADDED 6,596,885 +3,414,358 +107.3% 5.02% $67.0M $10.15
2025 Q1 REDUCED 3,182,527 -1,212,000 -27.6% 1.51% $17.8M $5.58
7 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ORIC price (monthly, adj. close)
← Back to VR Adviser, LLC Holdings